OSTEOPOROSIS RESEARCH Research Awards Osteoporosis Canada is proud to support clinical, translational and health-outcomes research that focuses on the high fracture-risk population and more specifically, preventing fractures and their negative […]

General Inquiries Contact Us We look forward to connecting with you! Please choose from one of the following ways to contact us: 1-800 Information Line The 1-800 Information Line is […]

UPDATE As the COVID-19 situation and directives from public health agencies continue to evolve quickly, the Tamarack Ottawa Race Weekend and Scotiabank Ottawa Marathon have decided to temporarily pause new […]

Osteoporosis Canada is pleased to announce that effective November 1, 2023 Dr. Sonia Singh will be joining the organization as the new OC National FLS Implementation Lead, previously known as […]

Western Memorial Hospital, NL Western Memorial Hospital, NL Brookfield Chair In Fracture Prevention Funds New Fracture Liaison Service (Fls) Program In Corner Brook, Nl Brookfield Chair In Fracture Prevention Funds […]

SAC Members and Research MD, MSC, PHD AhmedNegm Dr. Ahmed Negm is a trained orthopedic surgeon with additional training in health research and rehabilitation sciences. Following his undergraduate medical training […]

Romosozumab EVENITY™ (romosozumab injection) Romosozumab, a sclerostin inhibitor, is the first new approach to the treatment of osteoporosis and fracture risk in almost a decade.Romosozumab (EVENITY™) significantly and rapidly (over […]

On September 29, 2015, two research articles were published online in the British Medical Journal (BMJ) concerning the effect of calcium intake on bone mineral density (BMD) and fracture reduction. […]

Important Changes to the Availability and Conditions of Use for Drugs Containing Calcitonin Calcitonin nasal spray for the treatment of osteoporosis is no longer available in Canada because of new […]